|
業務類別
|
Biotechnology |
|
業務概覽
|
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology byusing machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery. |
| 公司地址
| 101 South Street, Suite 900, Somerville, MA, USA, 02143 |
| 電話號碼
| +1 888 469-0055 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.generatebiomedicines.com |
| 員工數量
| 132 |
| Mr. Sean Martin |
Chief Legal Officer and General Counsel |
-- |
23/02/2026 |
| Mr. Michael Nally |
Chief Executive Officer and Director |
-- |
23/02/2026 |
| Dr. Gevorg Grigoryan |
Chief Technology Officer |
-- |
23/02/2026 |
| Ms. Beth Grous |
Chief People Officer |
-- |
23/02/2026 |
| Mr. Aarif Khakoo |
Chief Scientific Officer |
-- |
23/02/2026 |
| Ms. Laurie Lee |
Chief Medical Officer |
-- |
23/02/2026 |
| Dr. Jason Silvers, M.D. |
President and Chief Financial Officer |
-- |
23/02/2026 |
|
|
| Dr. Rupert Vessey, B.M.,D.Phil.,F.R.C.P.,M.A. |
Independent Director |
23/02/2026 |
| Mr. Michael Nally |
Chief Executive Officer and Director |
23/02/2026 |
| Mr. Noubar B. Afeyan |
Chairman of the Board |
23/02/2026 |
| Ms. Frances Arnold |
Independent Director |
23/02/2026 |
| Mr. Stephane Bancel |
Independent Director |
23/02/2026 |
| Ms. Marsha H. Fanucci |
Independent Director |
23/02/2026 |
| Ms. Jane Mendillo |
Independent Director |
23/02/2026 |
| Mr. Paul Parker |
Independent Director |
23/02/2026 |
| Dr. Nancy A. Simonian |
Independent Director |
23/02/2026 |
|
|
|
|
